Showing 881 - 900 results of 104,633 for search '(( 2 c decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.64s Refine Results
  1. 881
  2. 882

    Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

    Published 2019
    “…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10<sup>−5</sup>; D: p = 5.5 × 10<sup>−13</sup>), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”
  3. 883
  4. 884
  5. 885
  6. 886

    METH decreased basal pERK1/2 levels and potentiated ERK1/2 phosphorylation induced by 6-OHDA. by Amina El Ayadi (341955)

    Published 2013
    “…METH decreased activation of ERK 1/2 in a concentration-dependent manner (0, 0.5, and 1 mM at the 24 hr time point) and enhanced the activation of ERK1/2 after 6-OHDA exposure. …”
  7. 887
  8. 888
  9. 889

    Decreased <i>Pax2</i> expression in <i>p53<sup>−/−</sup></i> embryonic kidneys. by Zubaida Saifudeen (135684)

    Published 2012
    “…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”
  10. 890
  11. 891
  12. 892
  13. 893
  14. 894
  15. 895

    The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

    Published 2022
    “…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”
  16. 896
  17. 897
  18. 898
  19. 899
  20. 900

    (A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells by Masakatsu Yamashita (46657)

    Published 2011
    “…MeDIP assay was performed using an anti–5-methyl cytidine antibody (5-meC) and a control antibody (Cont.). …”